Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207) [clinicaltrials:NCT00158457]

Bio2RDF identifier

NCT00158457

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT00158457

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT00158457

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

40

http://www.w3.org/2001/XMLSchema#integer

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:6dfcbb44fa1f5eb7948bb7806905c9f2

brief summary [clinicaltrials_vocabulary:brief-summary]

In the context of Sub-s ...... and 96 weeks of treatment.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Simple Once Daily Triple Regim ...... Infected Patients (ANRS 1207)

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:8cda0e6f287e61e6525bb53c07423660]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:0b8982865af555bc802c755becc64672]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:41d1b6587e62ec4e534a6ce206b83797]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:5c358d9c548bd847550985686942d06c]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:83d3b7754dbdc6f3bbd07aec243b8b41]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:99b1b06db7e2add1d66b99af3f9911a0]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:c89a556c7cde64625b967473c669c79f]

Evaluation of the antiretroviral efficacy as first line treatment assessed as percentage of patients with viral load below 400 copies/ml at week 48 in the intention to treat (ITT) population S48 [clinicaltrials_resource:fc8b366735da57ae26408d5aeafdee16]

collaborator [clinicaltrials_vocabulary:collaborator]

French National Agency for Research on AIDS and Viral Hepatitis [clinicaltrials_resource:70aef9de6f48dc8b934933b4434a772f]

completion date [clinicaltrials_vocabulary:completion-date]

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT00158457 [clinicaltrials_resource:0e3d09ce7cbbb1e7430d816527b2cb3d]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2005-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

No

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

Tenofovir (TDF) [clinicaltrials_resource:55792dbf8d7b80185811c2580bd95de6]

Emtricitabine (FTC) [clinicaltrials_resource:8174c42127d54fc27e2a3c9f29be51c4]

Efavirenz (EFV) [clinicaltrials_resource:d915931f9d3002125036d568ba74877f]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Tenofovir [clinicaltrials_resource:38009e0aeec791fbe440de7f35ea38ca]

Tenofovir disoproxil [clinicaltrials_resource:777947d284e84939e482a906645bb5b6]

Efavirenz [clinicaltrials_resource:a23a5ff97d09b32565c38444f8a6ab2b]

Emtricitabine [clinicaltrials_resource:bcab48e50e5e357c9b174a9b5fd8cbad]

keyword [clinicaltrials_vocabulary:keyword]

HIV infection

http://www.w3.org/2001/XMLSchema#string

Naive patients

http://www.w3.org/2001/XMLSchema#string

Once a day

http://www.w3.org/2001/XMLSchema#string

Simplification regimen

http://www.w3.org/2001/XMLSchema#string

Sub-saharian Africa

http://www.w3.org/2001/XMLSchema#string

Treatment Naive

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2007-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

French National Agency for Research on AIDS and Viral Hepatitis [clinicaltrials_resource:70aef9de6f48dc8b934933b4434a772f]

location [clinicaltrials_vocabulary:location]

Centre de Traitement Ambulatoire, CHU de Fann [clinicaltrials_resource:341dfb868d234ed24159f2fcb268f0cb]

nct id [clinicaltrials_vocabulary:nct-id]

NCT00158457

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

1

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

Pilot Trial to Evaluate the Ef ...... etroviral Treatment in Senegal

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

ANRS 1207

http://www.w3.org/2001/XMLSchema#string

overall official [clinicaltrials_vocabulary:overall-official]

Roland Landman [clinicaltrials_resource:d36dcfc0323b6cd023d34906778b2a32]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Senegal: Ministere de la sante [clinicaltrials_resource:fec756a1d301484c99bdad9daeea962c]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

secondary id [clinicaltrials_vocabulary:secondary-id]

IMEA 025

http://www.w3.org/2001/XMLSchema#string

source [clinicaltrials_vocabulary:source]

French National Agency for Research on AIDS and Viral Hepatitis [clinicaltrials_resource:70aef9de6f48dc8b934933b4434a772f]

start date [clinicaltrials_vocabulary:start-date]

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT00158457 study design [clinicaltrials_resource:3bc3ea76b6016f3fefd8f572d2b8a733]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT00158457

verification date [clinicaltrials_vocabulary:verification-date]

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT00158457

http://www.w3.org/2001/XMLSchema#string

title

Simple Once Daily Triple Regim ...... Infected Patients (ANRS 1207)

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Simple Once Daily Triple Regim ...... ) [clinicaltrials:NCT00158457]

@en